In the third episode of the three-part podcast series by Adams & Adams on the IP enforcement of pharma in Africa, partners Danie Dohmen and Russell Bagnall, and in-house counsel Natasha Wright, talk to Managing IP about recent trends in pharmaceutical patent litigation in South Africa.
The experts discuss the nuances of the enforcement environment in South Africa amid the COVID-19 pandemic, specific pharma litigation enforcement proceedings, and the impact of the non-examination of patents, while providing examples to assist business leaders, innovators and consumers who work in the South African IP field.
About Adams & Adams
Adams & Adams is an internationally recognised and leading African law firm that specialises in providing intellectual property, corporate and commercial services.
The firm is firmly rooted in Africa – with a tenacious belief in the economic growth potential and spirit of the continent. The head office in Pretoria, the capital of South Africa, provides the perfect gateway through which our partners, supported by some 700 professionals and staff, render a broad range of legal services to clients in Africa and the rest of the world.
Through its associate offices and long established networks, the firm serves a global client base throughout the African continent - in matters of intellectual property, commercial law, property and litigation.
Related content
Podcast: Adams & Adams discuss trends in anti-counterfeiting across Africa
Podcast: Adams & Adams discuss the challenges of registration in Africa
You can find all Managing IP podcasts here.
